Zusammenfassung
Die aktuelle internationale Sepsisleitlinie aus dem Jahr 2021 basiert auf der Arbeit eines Panels von 60 internationalen Experten aus verschiedenen Bereichen. Sie beinhaltet insgesamt 93 Empfehlungen, wobei einige Empfehlungen verglichen mit der Leitlinienversion von 2016 neue Aspekte beinhalten. Der vorliegende Beitrag bietet eine subjektive Zusammenstellung zweier internistischer Intensivmediziner, die einige Aspekte aufzeigen, insbesondere Veränderungen innerhalb der Leitlinie im Vergleich zur vorherigen Version. Der Fokus liegt auf den Bereichen Screening, Sepsis-Campaign-Bündel, Flüssigkeits- und Vasopressorentherapie und adjuvante Therapien. Zudem wird in dieser Leitlinie erstmalig das wichtige Thema der Langzeitfolgen für Sepsisüberlebende und deren Umfeld angesprochen.
Abstract
The current international sepsis guidelines from 2021 are based on the work of a panel of 60 international experts from various fields. They include a total of 93 recommendations, some of which include new aspects compared to the 2016 version of the guidelines. This article provides a subjective compilation by two internal medicine intensivists who highlight some aspects, especially of changes within the guidelines compared to the previous version. The focus is on the fields of screening, sepsis bundles, fluid and vasopressor treatment and adjuvant treatment. In addition, for the first time these guidelines address the important issue of long-term sequelae for sepsis survivors and their environment.
Literatur
Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C et al (2021) Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Crit Care Med 49:e1063–e143
Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C et al (2021) Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intens Care Med 47:1181–1247
Weiss SL, Peters MJ, Alhazzani W, Agus MSD, Flori HR, Inwald DP et al (2020) Executive summary: surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children. Intens Care Med 46:1–9 (https://www.ncbi.nlm.nih.gov/pubmed/32030528)
Alhazzani W, Moller MH, Arabi YM, Loeb M, Gong MN, Fan E et al (2020) Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19). Intens Care Med 46:854–887 (https://www.ncbi.nlm.nih.gov/pubmed/32222812)
Alhazzani W, Moller MH, Arabi YM, Loeb M, Gong MN, Fan E et al (2020) Surviving Sepsis Campaign: Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19). Crit Care Med 48:e440–e469 (https://www.ncbi.nlm.nih.gov/pubmed/32224769)
Levy MM, Evans LE, Rhodes A (2018) The surviving sepsis campaign bundle: 2018 update. Crit Care Med 46:997–1000 (https://www.ncbi.nlm.nih.gov/pubmed/29767636)
Pro CI, Yealy DM, Kellum JA, Huang DT, Barnato AE, Weissfeld LA et al (2014) A randomized trial of protocol-based care for early septic shock. N Engl J Med 370:1683–1693 (https://www.ncbi.nlm.nih.gov/pubmed/24635773)
Investigators A, Group ACT, Peake SL, Delaney A, Bailey M, Bellomo R et al (2014) Goal-directed resuscitation for patients with early septic shock. N Engl J Med 371:1496–1506 (https://www.ncbi.nlm.nih.gov/pubmed/25272316)
Mouncey PR, Osborn TM, Power GS, Harrison DA, Sadique MZ, Grieve RD et al (2015) Trial of early, goal-directed resuscitation for septic shock. N Engl J Med 372:1301–1311 (https://www.ncbi.nlm.nih.gov/pubmed/25776532)
Damiani E, Donati A, Serafini G, Rinaldi L, Adrario E, Pelaia P et al (2015) Effect of performance improvement programs on compliance with sepsis bundles and mortality: a systematic review and meta-analysis of observational studies. PLoS ONE 10:e125827
Islam MDM, Nasrin T, Walther BA, Wu C‑C, Yang H‑C, Li Y‑C (2019) Prediction of sepsis patients using machine learning approach: a meta-analysis. Comput Methods Programs Biomed 170:1–9
Downing NL, Rolnick J, Poole SF, Hall E, Wessels AJ, Heidenreich P et al (2019) Electronic health record-based clinical decision support alert for severe sepsis: a randomised evaluation. BMJ Qual Saf 28:762
Hooper MH, Weavind L, Wheeler AP, Martin JB, Gowda SS, Semler MW et al (2012) Randomized trial of automated, electronic monitoring to facilitate early detection of sepsis in the intensive care unit*. Crit Care Med 40:2096–2101
Shimabukuro DW, Barton CW, Feldman MD, Mataraso SJ, Das R (2017) Effect of a machine learning-based severe sepsis prediction algorithm on patient survival and hospital length of stay: a randomised clinical trial. BMJ Open Respir Res 4:e234
Seymour CW, Liu VX, Iwashyna TJ, Brunkhorst FM, Rea TD, Scherag A et al (2016) Assessment of clinical criteria for sepsis: for the third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA 315:762–774
Serafim R, Gomes JA, Salluh J, Povoa P (2018) A comparison of the quick-SOFA and systemic inflammatory response syndrome criteria for the diagnosis of sepsis and prediction of mortality: a systematic review and meta-analysis. Chest 153:646–655 (https://www.ncbi.nlm.nih.gov/pubmed/29289687)
Liu VX, Lu Y, Carey KA, Gilbert ER, Afshar M, Akel M et al (2020) Comparison of early warning scoring systems for hospitalized patients with and without infection at risk for in-hospital mortality and transfer to the intensive care unit. JAMA Netw Open 3:e205191
Rivers E et al (2001) Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345:1368–1377
Meyhoff TS, Hjortrup PB, Wetterslev J, Sivapalan P, Laake JH, Cronhjort M et al (2022) Restriction of intravenous fluid in ICU patients with septic shock. N Engl J Med 386:2459–2470
Network NH Lung, and Blood Institute Prevention and Early Treatment of Acute Lung Injury Clinical Trials, Shapiro NI, Douglas IS, Brower RG, Brown SM, Exline MC et al (2023) Early restrictive or liberal fluid management for sepsis-induced hypotension. N Engl J Med 388:499–510
Rochwerg B, Alhazzani W, Sindi A, Heels-Ansdell D, Thabane L, Fox-Robichaud A et al (2014) Fluid resuscitation in sepsis: a systematic review and network meta-analysis. Ann Intern Med 161:347–355 (https://www.ncbi.nlm.nih.gov/pubmed/25047428)
Semler MW, Self WH, Wanderer JP, Ehrenfeld JM, Wang L, Byrne DW et al (2018) Balanced Crystalloids versus saline in critically ill adults. N Engl J Med 378:829–839 (https://www.ncbi.nlm.nih.gov/pubmed/29485925)
Brown RM, Wang L, Coston TD, Krishnan NI, Casey JD, Wanderer JP et al (2019) Balanced Crystalloids versus saline in sepsis. A secondary analysis of the SMART clinical trial. Am J Respir Crit Care Med 200:1487–1495
Zampieri FG, Machado FR, Biondi RS, Freitas FGR, Veiga VC, Figueiredo RC et al (2021) Effect of intravenous fluid treatment with a balanced solution vs 0.9 % saline solution on mortality in critically ill patients. JAMA 326:818–829
Prescott HC, Iwashyna TJ (2018) Improving sepsis treatment by embracing diagnostic uncertainty. Ann Am Thorac Soc 16:426–429
Rhee C, Kadri SS, Danner RL, Suffredini AF, Massaro AF, Kitch BT et al (2016) Diagnosing sepsis is subjective and highly variable: a survey of intensivists using case vignettes. Crit Care 20:89
Klouwenberg PMCK, Cremer OL, van Vught LA, Ong DSY, Frencken JF, Schultz MJ et al (2015) Likelihood of infection in patients with presumed sepsis at the time of intensive care unit admission: a cohort study. Crit Care 19:319
Seymour CW, Gesten F, Prescott HC, Friedrich ME, Iwashyna TJ, Phillips GS et al (2017) Time to treatment and mortality during mandated emergency care for sepsis. N Engl J Med 376:2235–2244
Liu VX, Fielding-Singh V, Greene JD, Baker JM, Iwashyna TJ, Bhattacharya J et al (2017) The timing of early antibiotics and hospital mortality in sepsis. Am J Respir Crit Care Med 196:856–863
Hagel S, Bach F, Brenner T, Bracht H, Brinkmann A, Annecke T et al (2022) Effect of therapeutic drug monitoring-based dose optimization of piperacillin/tazobactam on sepsis-related organ dysfunction in patients with sepsis: a randomized controlled trial. Intens Care Med 48:311–321
Tian DH, Smyth C, Keijzers G, Macdonald SP, Peake S, Udy A et al (2020) Safety of peripheral administration of vasopressor medications: a systematic review. Emerg Med Australas 32:220–227
Loubani OM, Green RS (2015) A systematic review of extravasation and local tissue injury from administration of vasopressors through peripheral intravenous catheters and central venous catheters. J Crit Care 30:653.e9–653.e17
Delaney A, Finnis M, Bellomo R, Udy A, Jones D, Keijzers G et al (2020) Initiation of vasopressor infusions via peripheral versus central access in patients with early septic shock: a retrospective cohort study. Emerg Med Australas 32:210–219
Annane D, Renault A, Brun-Buisson C, Megarbane B, Quenot JP, Siami S et al (2018) Hydrocortisone plus fludrocortisone for adults with septic shock. N Engl J Med 378:809–818
Venkatesh B, Finfer S, Cohen J, Rajbhandari D, Arabi Y, Bellomo R et al (2018) Adjunctive Glucocorticoid therapy in patients with septic shock. N Engl J Med 378:797–808
Gordon AC, Mason AJ, Thirunavukkarasu N, Perkins GD, Cecconi M, Cepkova M et al (2016) Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: the VANISH randomized clinical trial. JAMA 316:509–518
Rygard SL, Butler E, Granholm A, Moller MH, Cohen J, Finfer S et al (2018) Low-dose corticosteroids for adult patients with septic shock: a systematic review with meta-analysis and trial sequential analysis. Intensive Care Med 44:1003–1016
Fang F, Zhang Y, Tang J, Lunsford LD, Li T, Tang R et al (2019) Association of corticosteroid treatment with outcomes in adult patients with sepsis: a systematic review and meta-analysis. JAMA Intern Med 179:213–223
Lamontagne F, Masse M‑H, Menard J, Sprague S, Pinto R, Heyland DK et al (2022) Intravenous vitamin C in adults with sepsis in the intensive care unit. N Engl J Med 386:2387–2398
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
M. Kochanek und S. David geben an, dass kein Interessenkonflikt besteht.
Für diesen Beitrag wurden von den Autor/-innen keine Studien an Menschen oder Tieren durchgeführt. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.
Additional information
Dieser Beitrag wurde in der Zeitschrift Die Innere Medizin (2023) 64(10):939–945. https://doi.org/10.1007/s00108-023-01585-z erstveröffentlicht. Zweitpublikation mit freundlicher Genehmigung der Autoren.
QR-Code scannen & Beitrag online lesen
Rights and permissions
About this article
Cite this article
Kochanek, M., David, S. Die aktuelle Sepsisleitlinie. Wien klin Mag 27, 38–43 (2024). https://doi.org/10.1007/s00740-024-00527-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00740-024-00527-1